Access Pharmaceuticals Inc.
Description
pulled from site's meta descriptionAccess Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients.
This is an automatically generated AboutUs page for Accesspharma.biz. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- access
- pharmaceuticals
- access pharmaceuticals
- pharmaceutical
- ACCP
- ACCP.OB
- mucositis
- MuGard
- supportive care
- mouth ulcers
- oral
- rinse
- 510(k)
- device
- clinical trial
- oncology
- oncologic
- cancer
- tumor
- tumour
- tumors
- tumours
- radiation
- chemotherapy
- platinum
- DACH
- cisplatin
- oxaliplatin
- polymer
- platinate
- polymer platinate
- AP-5280
- AP5280
- AP-5346
- AP5346
- ProLindac
- HPMA
- peptide
- GFLG
- controlled release
- drug delivery
- pH-sensitive
- linker
- polymer therapeutic
- daunorubicin
- doxorubicin
- anthracycline
- prodrug
- EPR effect
- macromolecule
- vitamin
- vitamin-mediated
- vitamin B12
- cobalamin
- biotin
- folate
- folic acid
- oral drug delivery
- disease targeting
- protein
- proteins
- antibody
- antibodies
- fragment
- antibody fragment
- antibody fragments
- insulin
- diabetes
- nanoparticle
- nanocarrier
- hydrogel
- AKC